I believe that like it or not in a few years big Pharma
I believe that like it or not in a few years big Pharma will be heavily into the cannabis market. The question for companies like OWCP may be, do they allow themselves to be acquired, or do they partner and remain somewhat independent.
It's my hope that OWCP develop several partnerships for its products, but remains independent.
In most partnerships where big Pharma takes over developmental costs, as well as providing for manufacturing, distribution and sales, they will get the substantially greater part of sales revenue. The good news is even ten percent of the total sales for many of the products being developed by OWCP could still run into hundreds of millions with virtually no further costs to them once the partnership is put into place, and 0WCP should receive substantial funds up front in gaining the partnership.
I agree with all who believe that the company's silence has a lot to do with the fact that they're negotiating with perhaps several other companies in developing partnerships.
Gary
2
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...
Continue Reading
Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...
Continue Reading
A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...
Continue Reading
In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...
Continue Reading
Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...
Continue Reading
Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...
Continue Reading
Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...
Continue Reading
Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...
Continue Reading
Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...
Continue Reading
The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...
Continue Reading
Top 5 Most Recently Viewed Articles
CLIQ Digital AG Faces Critical Vote from Major Shareholder CLIQ Digital AG, a well-known entity in the digital services industry, recently found itself at a pivotal moment. Dylan Media B.V., the largest shareholder in CLIQ Digital, has made headlines by declaring its intent to vote against a significant item on the agenda at the upcoming Annual General Meeting. This...
Continue Reading
CW Bancorp Declares a Refreshing Quarterly Dividend CW BANCORP (OTCQX: CWBK), the parent company of CommerceWest Bank, recently announced the approval of a quarterly cash dividend by its Board of Directors. This step signifies the company's ongoing dedication to maximizing shareholder value. The Board declared a cash dividend of $0.23 per common share, illustrating the...
Continue Reading
HBCU Executive Leadership Institute: Five Years of Excellence The HBCU Executive Leadership Institute at Clark Atlanta University has reached a significant milestone, celebrating its fifth anniversary. This program is dedicated to nurturing and developing the next generation of presidents and executives at Historically Black Colleges and Universities (HBCUs). It is an...
Continue Reading
Kuehn Law Investigates StubHub Holdings for Shareholder Rights NEW YORK – Kuehn Law, PLLC, a law firm dedicated to shareholder litigation, is focused on examining whether certain officers and directors at StubHub Holdings, Inc. (NYSE: STUB) have acted against the interests of shareholders. The firm’s investigation is driven by allegations in a federal securities...
Continue Reading
In real estate financing, money lenders occupy a distinctive niche. They offer alternative funding solutions that diverge from traditional banking institutions. A hard money lender presents a viable option for those seeking quick access to capital or needing help securing loans through conventional means. Comprehending the nuances of this financing avenue is paramount...
Continue Reading